Phaarmasia Ltd.

32.10 -2.41 ▼-7.0%

23 February 2024, 04:01:00 PM
Volume: 4,365

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.phaarmasia.in
Market Cap 21.96 Cr.
Enterprise Value(EV) 21.73 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -1.59 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.98 Trailing Twelve Months Ending 2023-12
Book Value / Share 8.17 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.94 Calculated using Price: 32.17
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.68 Cr. 6,826,960 Shares
FaceValue 10
About Phaarmasia Ltd.
The company was incorporated on February 6,1981 as Phaarmasia Private Limited, and the company was converted into a public limited company, Phaarmasia Limited on February 15, 1992, it is into manufacturing of pharmaceutical formulations. Company's facilities are spread over in 3 acres of land with built up area of 90,000 sq.ft.

Phaarmasia Ltd. Delivery

Delivered Qty
Traded Qty

Phaarmasia Ltd. Performance

1 Day
-6.98%
1 Week
-9.70%
1 Month
-6.96%
3 Month
+20.68%
6 Month
+27.13%
1 Year
+30.75%
2 Year
+15.88%
5 Year
+114.00%
10 Year
+196.67%

Phaarmasia Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 1.86 0.55 2.16 7.54 9.51 6.08 3.36 -17.96 -17.5
Return on Capital Employed (%) 5.28 3.35 3.63 9.32 10.35 11.07 5.24 -18 -19.24
Return on Assets (%) 0.86 0.22 0.85 2.76 2.82 1.61 1.12 -7.18 -5.08

Phaarmasia Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 13 12 12 12 13 13 14 12 11 10
Non Curr. Liab. 0 0 1 1 1 1 0 0 0 0
Curr. Liab. 6 6 7 9 20 19 8 9 17 17
Minority Int.
Equity & Liab. 19 19 20 22 33 34 22 21 28 28
Non Curr. Assets 16 14 14 14 14 14 13 13 13 13
Curr. Assets 3 4 6 8 19 20 9 8 15 15
Misc. Exp. not W/O
Total Assets 19 19 20 22 33 34 22 21 28 28

Phaarmasia Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 19 22 14 20 24 24 20 17 27 28
Other Income 0 1 1 1 1 1 1 0 1 1
Total Income 19 22 15 21 25 25 21 18 28 29
Total Expenditure -18 -21 -14 -20 -23 -24 -20 -19 -29 -29
PBIDT 1 1 1 1 1 1 1 -1 -1 -1
Interest 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items 0
PAT 0 0 0 1 1 1 0 -2 -1 -1
Adjusted EPS 0 0 0 1 1 1 0 -2 -2 -2

Phaarmasia Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 1 0 0 0 0 1
Cash Fr. Inv. 0 0 0 0 -1 0 0 0
Cash Fr. Finan. 0 0 0 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 1

Phaarmasia Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 73.51 73.51 73.51 73.51 73.51 73.51 73.51 73.51 73.51
Public 26.49 26.49 26.49 26.49 26.49 26.49 26.49 26.49 26.49
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Phaarmasia Ltd. Announcements

Fri, 16 Feb 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015
Wed, 14 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of unaudited financial results for the Quarter ended 31st December 2023.
Tue, 13 Feb 2024
Unaudited Financial Results For The Quarter Ended 31St December 2023 - Regulation 33(3)(A) Of SEBI (LODR) Regulations 2015.
Unaudited financial results for the quarter ended 31st December 2023- Reg 33(3)(a) of SEBI (LODR) Reg 2015

Phaarmasia Ltd. Technical Scans

Fri, 23 Feb 2024
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Phaarmasia Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 374,572.18 1,560.95 +0.2%
Cipla Ltd. 118,375.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. 107,511.08 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. 97,345.81 6,742.15 -0.4%
Divi's Laboratories Ltd. 96,748.70 3,636.05 -0.3%
Zydus Lifesciences Ltd. 93,335.34 922.10 +1.9%
Torrent Pharmaceuticals Ltd. 88,913.00 2,627.10 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.06 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 31.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.56 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.33 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 69.96 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.39 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.51 2,627.10 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.00 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 4.57 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.42 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.80 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.43 2,627.10 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,627.10 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,627.10 +0.7%

Phaarmasia Ltd. FAQ's

What is Phaarmasia share price?

Can I buy Phaarmasia shares now?

What is the Market Cap of Phaarmasia?

What are the key metrics to analyse Phaarmasia?

What is the 52 Week High and Low of Phaarmasia?

What is the trend of Phaarmasia share price?